Clinical Trial Details
| Trial ID: | L1799 |
| Source ID: | NCT04582448 |
| Associated Drug: | Insulin Icodec |
| Title: | A Study Looking at How Insulin Icodec is Taken up in the Blood When Administered in Different Injection Sites in People With Type 2 Diabetes |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Diabetes Mellitus, Type 2 |
| Interventions: | DRUG: Insulin icodec |
| Outcome Measures: | Primary: AUCIco,0-inf,SD, Area under the serum insulin icodec concentration-time curve after a single dose, From 0 hours until infinity after trial product administration (pmol\*h/L), Day 1 | Secondary: Cmax,Ico,SD, Maximum observed serum insulin icodec concentration after a single dose, From 0 hours until infinity after trial product administration (pmol/L), Day 1|tmax,Ico,SD, Time to maximum observed serum insulin icodec concentration after a single dose, From 0 hours until infinity after trial product administration (hours), Day 1 |
| Sponsor/Collaborators: | Sponsor: Novo Nordisk A/S |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE1 |
| Enrollment: | 25 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2020-10-01 |
| Completion Date: | 2021-09-27 |
| Results First Posted: | |
| Last Update Posted: | 2023-01-20 |
| Locations: | Novo Nordisk Investigational Site, Mainz, 55116, Germany |
| URL: | https://clinicaltrials.gov/show/NCT04582448 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|